Abstract

BackgroundMicroangiopathy, which features may be detected by nailfold videocapillaroscopy (NVC), is an early aspect of systemic sclerosis (SSc). It is not a static event, but dynamic and may progress through...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Response to: Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis
Vanessa Smith ... Maurizio Cutolo
Arthritis Research & Therapy | VOL. 13
Vanessa Smith, et. al.Vanessa Smith ... Maurizio Cutolo
01 Jan 2009
AB0782 Autoantibodies and nailfold capillaroscopic patterns in systemic sclerosis patients
...
Annals of the Rheumatic Diseases | VOL. 71
, et. al. ...
01 Jun 2013
SAT0257 THE SIGNIFICANCE ON THE TRANSITION THROUGH DIFFERENT PATTERNS OF NAILFOLD MICROVASCULAR DAMAGE ON THE COURSE OF SYSTEMIC SCLEROSIS
Nemanja Damjanov ... Slavica Pavlov-Dolijanovic
-
Nemanja Damjanov, et. al.Nemanja Damjanov ... Slavica Pavlov-Dolijanovic
01 Jun 2019
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study.
G Ferrari ... L Carmisciano
Rheumatology (Oxford, England) | VOL. 59
G Ferrari, et. al.G Ferrari ... L Carmisciano
17 Sep 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers